- No file added yet -
Trade-offs of adjuvant immunotherapy in stage-III melanoma−a clinicians' view?
Version 2 2024-06-06, 05:21Version 2 2024-06-06, 05:21
Version 1 2023-03-17, 05:06Version 1 2023-03-17, 05:06
journal contribution
posted on 2024-06-06, 05:21 authored by Ann LivingstoneAnn LivingstoneTrade-offs of adjuvant immunotherapy in stage-III melanoma−a clinicians' view?
History
Journal
Asia Pacific Journal of Clinical OncologyVolume
15Pagination
141-141Location
London, Eng.Publisher DOI
ISSN
1743-7555Language
engPublication classification
E3.1 Extract of paperIssue
S9Publisher
WileyUsage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC